Chimeric Antigen Receptor Technology

IFN-γ Receptor Knockout Extends CAR-T Cell Lifespan and Boosts Tumor Combat

It leverages CRISPR/Cas9 disruption of the interferon-γ receptor to boost CAR-T cell durability ahead of planned solid tumor trials.